DreaMed
PrivateLast Round
Early Funding
Aug 19, 2024
Total Funding Raised
$23.08M
Company Overview
DreaMed is a healthcare technology company that offers a diabetes management system aimed at optimizing intensive insulin therapy through advanced machine learning and personalized treatment plans.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Vertical SaaS, Precision Medicine, Telemedicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DreaMed Comps
Public and private peers based on sector, stage, and business model.
DreaMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 19, 2024 | ||||
| Grant | Feb 23, 2023 | ||||
| Grant | Nov 24, 2020 | ||||
| Grant | Aug 10, 2020 | ||||
| Series A | Jul 25, 2016 | ||||
Grant | Feb 3, 2016 |
Key People
Founding team and executive leadership
DreaMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Millhouse LLC | Series A |
| eHealth Ventures | Early Funding |
| Medtronic | Seed |
DreaMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DreaMed's valuation, stock price, and market status.
